[HTML][HTML] The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy

HH Han, HM Wang, P Jangili, M Li, L Wu… - Chemical Society …, 2023 - pubs.rsc.org
Cancer remains as one of the most significant health problems, with approximately 19
million people diagnosed worldwide each year. Chemotherapy is a routinely used method to …

Piano stool Ru (II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade

S Swaminathan, J Haribabu, N Balakrishnan… - Coordination chemistry …, 2022 - Elsevier
The popularity of RAPTA-C in in vivo studies has steered the way for complexes of the type
[Ru (η 6-arene)(X)(Y)(Z)] n+ (where X, Y and Z are monodentate ligands) to be developed …

Recent progress on tubulin inhibitors with dual targeting capabilities for cancer therapy

W Shuai, G Wang, Y Zhang, F Bu, S Zhang… - Journal of Medicinal …, 2021 - ACS Publications
Microtubules play a crucial role in multiple cellular functions including mitosis, cell signaling,
and organelle trafficking, which makes the microtubule an important target for cancer …

[HTML][HTML] Multidrug resistance of cancer cells and the vital role of P-glycoprotein

C Karthika, R Sureshkumar, M Zehravi, R Akter, F Ali… - Life, 2022 - mdpi.com
P-glycoprotein (P-gp) is a major factor in the multidrug resistance phenotype in cancer cells.
P-gp is a protein that regulates the ATP-dependent efflux of a wide range of anticancer …

Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy

OM Soltan, ME Shoman, SA Abdel-Aziz… - European Journal of …, 2021 - Elsevier
Protein kinases have grown over the past few years as a crucial target for different cancer
types. With the multifactorial nature of cancer, and the fast development of drug resistance …

Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective

J Wang, DD Miller, W Li - Drug discovery today, 2022 - Elsevier
Highlights•Colchicine binding site inhibitors (CBSIs) emerge as new generations of tubulin
inhibitors.•CBSIs are less susceptible to multidrug resistance than FDA-approved tubulin …

[HTML][HTML] Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions

DJ Fu, T Wang - Journal of Hematology & Oncology, 2023 - Springer
NEDDylation, a post-translational modification through three-step enzymatic cascades,
plays crucial roles in the regulation of diverse biological processes. NEDD8-activating …

Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action

A Khoury, KM Deo, JR Aldrich-Wright - Journal of inorganic biochemistry, 2020 - Elsevier
Current platinum-based drugs used in chemotherapy, like cisplatin and its derivatives, are
greatly limited due to side-effects and drug resistance. This has inspired the search for novel …

Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent …

YX Sun, J Song, LJ Kong, BB Sha, XY Tian… - European Journal of …, 2022 - Elsevier
As the continuation of our work on the development of tubulin inhibitors with potential
anticancer activities, novel bis-substituted aromatic amide dithiocarbamate derivatives were …

Design, synthesis, and biological evaluation of stable colchicine-binding site tubulin inhibitors 6-aryl-2-benzoyl-pyridines as potential anticancer agents

H Chen, S Deng, N Albadari, MK Yun… - Journal of medicinal …, 2021 - ACS Publications
We previously reported a potent tubulin inhibitor CH-2-77. In this study, we optimized the
structure of CH-2-77 by blocking metabolically labile sites and synthesized a series of CH-2 …